Sydney, Australia 30th October 2014 Genetic Signatures Ltd today announced the appointment of Pat Noland to its Board of Directors in the capacity of non-executive director. Mr. Noland currently serves as Chief Executive Officer of StrataDx, a leading provider of high-quality pathology services in the dermatology, urology, podiatry, oral pathology, gastroenterology, and gynecology segments. Mr.…

Genetic Signatures has increased its suite of CE- marked IVD products with the registration of the EasyScreen™ Enteric Bacteria Detection Kit. The EasyScreen™ Enteric Bacteria Detection Kit is a real-time PCR kit for the detection of i) Salmonella spp., (ii) Campylobacter spp., (iii) Shigella spp., (iv) Yersinia enterocolitica, (v) toxigenic C. difficile and (vi) Listeria…

Genetic Signatures has recently appointed Mike Aicher to the company’s Board of Directors as Executive Director – U.S. Operations. Mr. Aicher was CEO of National Genetics Institute (NGI), a company he co-founded in 1991, that later became a wholly owned subsidiary of Laboratory Corporation of America (LabCorp). More recently, Mr. Aicher led LabCorp’s Western Division…

We are pleased to announce that we have been granted TGA approval for our first IVDs in Australia. The following products are now listed on the Australian Register of Therapeutic Goods (ARTG). [table id=23 /]   The next products that will be registered are SP003 EasyScreen™ Sample Processing Kit  (Mag Beads) and EV001 (& HT) EasyScreen™ Enteric Viral Detection Kit.

Two recent publications highlight the clinical performance of Genetic Signatures EasyScreen™ Enteric Pathogen Detection Assays. The most recent publication by Stark et al. evaluates the clinical performance of the EasyScreen™ Enteric Protozoan Detection Kit. Stark D, Roberts T, Marriott D, Harkness J. Evaluation of the EasyScreen™ Enteric Parasite Detection Kit for the detection of Blastocystis spp., Cryptosporidium spp., Dientamoeba fragilis, Entamoeba complex, and Giardia intestinalis from clinical stool samples. Diagnostic Microbiology…

Genetic Signatures will be presenting and exhibiting at The Australian Society for Microbiology, Annual Scientific Meeting, from 6 – 9 July 2014 in Melbourne, Australia. The Australian Society for Microbiology Annual Scientific Meeting is the largest microbiology conference held in Australia and attracts approximately 600 microbiologists, allied professionals, researchers and academics from across the country…

Genetic Signatures will exhibit at the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), which will be held in Barcelona, Spain from the 10th to the 13th of May 2014. ECCMID provides a forum for delegates to update their knowledge and learn about the latest innovations in the field of infectious diseases and…

Dr John Melki, CEO Genetic Signatures, will be presenting on 3base™  the Science behind EasyScreen™ Molecular Diagnostic Assays at the upcoming Molecular Microbiology Meeting (MMM 2014). MMM2014 will be held on 5-6 March at WatervieW in Bicentennial Park, Sydney, NSW, Australia and provides a forum for research scientists, laboratory staff and clinicians to share the latest…

Genetic Signatures is in the final stages of clinical validation of an expanded target offering for the EasyScreen™ Enteric Bacterial detection panel. The new optional multiplex real-time PCR mix C will include targets for Aeromonas hydrophila, Vibrio cholerae/Vibrio parahaemolyticus, and Shiga Toxigenic E. coli (stx1/stx2). This will increase the number of targets in the EasyScreen™ Enteric Bacterial Detection…

Genetic Signatures will be exhibiting at The Australian Society for Microbiology, Annual Scientific Meeting, from 7 – 10 July 2013 in Adelaide, Australia. Genetic Signatures will showcase the latest products in their EasyScreen range for the detection of infectious disease including kits for diagnosing bacterial, viral and protazoan causes of gastroenteritis, including toxigenic and hypervirulent C. difficile, direct…